Population-based retrospective nested case-control study evaluating effectiveness of GARDASIL™ /GARDASIL™9 against adult-onset recurrent respiratory papillomatosis (AoRRP) in Sweden, Denmark, and Norway (V503-088)First published 05/10/2022 Last updated 21/05/2025 EU PAS number: EUPAS48452StudyOngoing
Karolinska InstitutetSweden First published: 01/02/2024Last updated 01/02/2024 InstitutionEducational Institution
Clinical Trials Disclosure Merck Sharp & Dohme LLC ClinicalTrialsDisclosure@merck.comStudy contactClinicalTrialsDisclosure@merck.com